PhD Students – At some point in your PhD, you will write a literature review. Use these 5 tools to 10x your literature review process. 𝐅𝐢𝐧𝐝𝐢𝐧𝐠 𝐩𝐚𝐩𝐞𝐫𝐬 𝐟𝐨𝐫 𝐲𝐨𝐮𝐫 𝐥𝐢𝐭𝐞𝐫𝐚𝐭𝐮𝐫𝐞 𝐫𝐞𝐯𝐢𝐞𝐰 1. 𝐑 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 → Notifies you as soon as a relevant

Liver involvement is common in ADKPD. @SitaArjune performed an in-depth analysis on this topic in a large cohort. Liver Manifestations in Autosomal Dominant Polycystic Kidney Disease (ADPKD) and their impact on quality of life academic.oup.com/ckj/article/do…

PhD Students - Do you want to learn how to do research? If yes, check out these free resources. 𝐄𝐥𝐬𝐞𝐯𝐢𝐞𝐫 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡𝐞𝐫 𝐀𝐜𝐚𝐝𝐞𝐦𝐲 offers free resources. Here are 10 of my favorite resources. 𝟏. 𝐇𝐨𝐰 𝐭𝐨 𝐰𝐫𝐢𝐭𝐞 𝐚 𝐥𝐢𝐭𝐞𝐫𝐚𝐭𝐮𝐫𝐞 𝐫𝐞𝐯𝐢𝐞𝐰

🫘Approach to autosomal dominant tubulointerstitial kidney disease NDT Hans-Joachim Anders academic.oup.com/ndt/article/38…

🧬 Genetics can be tricky, but you’re not alone! 🎙️Join us in the 29th episode of our #ERAPodcast #APinchOfSalt featuring Emilie Cornec-Le Gall as we explore genetics and kidney disease. 🎧 Hit play now ⁣👉 bit.ly/3SdsxU0

Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic cause of kidney failure. This study found that the combined use of both risk scores was associated with higher ability to identify rapid progressors and resulted in a better stratification, notably

🩺 Polycystic kidney disease: risks, diagnosis, and uncertainties 🎙️Join us in the 30th episode of our #ERAPodcast #APinchOfSalt, with Roman Ulrich Müller as we unpack the complexities of PKD. 🎧 Hit play now ⁣👉 bit.ly/3SdsxU0

📢 Join us at the Neph-Manual e-seminar: *Kidney diseases and pregnancy, and the relationship between complicated pregnancies and kidney diseases* 📅 January 8, 2025, 5:00 PM (CET)⁣ 🆕The live e-seminars are translated into 7 languages Register now 👉 bit.ly/3ZTQseZ

¿La mujer más valiente? María Corina Machado es el ser humano más valiente y congruente del siglo XXI, junto con Alexei Navanly

4.047 trasplantes renales registrados por la Organización Nacional de Trasplantes en 2024. GRACIAS 👏👏

Nephrectomy in Autosomal Dominant Polycystic Kidney Disease: A consensus statement of the ERA Genes & Kidney Working Group 🔓doi.org/10.1093/ndt/gf… ERA - European Renal Association

Original Article: Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease (EMPA-KIDNEY trial) nej.md/3NE3W7K Editorial: Another Win for SGLT2 Inhibitors in Chronic Kidney Disease nej.md/41qn5Ss #Nephrology

🤓 #GTERH #Senefro

A patient with CKD5D receiving haemodialysis treated with denosumab 🗣️ Speaker: Maria Jesus Lloret, Spain Juan Miguel Diaz-Tocados, Spain 👩‍👩‍👦Panellists: Marie-Helene Lafage-Proust, France Bente Langdahl, Denmark 🧑‍⚖️Moderator: Syazrah Salam, United Kingdom

Today in #PiS: "When should the nephrologist think about genetics in patients with glomerular diseases?". This review paper is led by #NefroPuigvert experts! 📜-->pubmed.ncbi.nlm.nih.gov/40115110

Gout and Hyperuricemia In ADPKD #ADPKD #CKD #Gout #Hyperuricemia #KDIGO Dr. Divya Bajpai 🇮🇳 Smita Divyaveer, MD, DM #NephroNuggets Sowrabha Rajanna Suman Behera Elba Medina Subashri Dr. Hardik Patel 🩺💉 Mónica Furlano Dr Priti MD,FASN🇮🇳 (प्रिति) SABARINATH S MD,DM,PDF(Renal Tx),FASN,FISN Milagros Flores Tanuj Jithu Kurian🇮🇳 manjusha yadla Jasmine Sethi Kajaree Giri

Presented at #ERA25: In the CONFIDENCE trial in persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results:

Interventions that retard CKD progression

Cystinosis usually needs early and strict cysteamine treatment. Yet this case had a good outcome despite late and unconventional therapy 👉 doi.org/10.1016/j.nefr… #Nefrologìa #nephrology #Cystinosis Roser Torra Mónica Furlano

1/ 🧵 ¿Todos los riñones donados de donante fallecido son iguales? ❌ No Desde 2014 en EE.UU. se utiliza el KDRI/KDPI para estimar la calidad de un riñón antes de trasplantarlo. Te explico qué es, cómo surgió, sus ventajas, limitaciones y futuro.